Devatis AG DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, News

Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

Virtual Booth

Contact Supplier

Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

FINISHED DOSAGE FORMULATIONS

48 FDF Dossiers, 48 Europe

48 FDF Dossiers
48 Europe

INSPECTIONS & REGISTRATIONS

1 EDQM

inspections
1 EDQM

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Devatis AG was founded in 2018 in Cham, Switzerland. Behind Devatis AG is EastPharma Ltd, which was established in 2006 with the aim of becoming a major player in the pharmaceutical industry and had been listed on London Stock Exchange (LSE) between 2008 and August 2019. Currently, the porfolio of Devatis AG consists of hematology, oncology, calcimimetics and antibiotics products and is still growing into other therapeutic areas such as cardiology and anti-fungal. DEVA Holding, pioneering Turkish pharmaceutical company, was founded in 1958 by group of medical doctors and pharmacists with main scope of business including manufacturing.